Harmonized Data Quality Indicators Maintain Data Quality in Long-Term Safety Studies Using Multiple Sclerosis Registries/Data Sources: Experience from the CLARION Studyclinical epidemiologyIF3.22024-10-010OAAI
Unveiling APOL1 haplotypes in a predominantly African-American cohort of kidney transplant patients: a novel classification using probe-independent quantitative real-time PCRFRONTIERS IN MEDICINEIF32024-04-100OAAI
Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims databaseCARDIOVASCULAR DIABETOLOGYIF10.62024-01-091OAAI
Inflammaging, cellular senescence, and cognitive aging after traumatic brain injury创伤性脑损伤后的炎症,细胞衰老和认知老化NEUROBIOLOGY OF DISEASEIF5.62023-05-0119OAAI
Cervical immobilisation in elderly patients with a suspected cervical spine fracture: a retrospective studyEUROPEAN JOURNAL OF EMERGENCY MEDICINEIF4.22023-04-240PRE
Quince extract resists atherosclerosis in rats by down-regulating the EGFR/PI3K/Akt/GSK-3β pathwayBIOMEDICINE & PHARMACOTHERAPYIF7.52023-04-0117OAAI
Efficacy and Safety of TiNO-Coated Stents versus Drug-Eluting Stents in Acute Coronary Syndrome: Systematic Literature Review and Meta-AnalysisBIOMEDICINESIF3.92022-12-073OAAI
The Candida albicans virulence factor candidalysin polymerizes in solution to form membrane pores and damage epithelial cellsELIFEIF02022-09-2921OA
Do Different Sutures with Triclosan Have Different Antimicrobial Activities? A Pharmacodynamic ApproachANTIBIOTICS-BASELIF4.62022-09-034OA
Abiraterone acetate versus docetaxel for metastatic castration-resistant prostate cancer: a cohort study within the French nationwide claims databaseEXPERT REVIEW OF CLINICAL PHARMACOLOGYIF32022-08-256PRE
Do Triclosan Sutures Modify the Microbial Diversity of Surgical Site Infections? A Systematic Review and Meta-AnalysisMICROORGANISMSIF4.22022-04-285OAAI
How Long Do Implanted Triclosan Sutures Inhibit Staphylococcus aureus in Surgical Conditions? A Pharmacological ModelPHARMACEUTICSIF5.52022-02-283OAAI
Patients with stable coronary artery disease and type 2 diabetes but without prior myocardial infarction or stroke and THEMIS-like patients: real-world prevalence and risk of major outcomes from the SNDS French nationwide claims databaseCARDIOVASCULAR DIABETOLOGYIF10.62021-11-256OAAI
Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims dataBMC MEDICAL RESEARCH METHODOLOGYIF3.42021-05-0113OAAI
Effectiveness of first-line cetuximab in wild-typeRASmetastatic colorectal cancer according to tumourBRAFmutation status from the EREBUS cohortBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32020-09-158OAAI
Factors associated with serious vehicular accidents: A cross-sectional study in hospital emergency roomsBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32020-07-122OAAI
Coronary Risks Associated with Diclofenac and Other NSAIDs: An UpdateDRUG SAFETYIF3.82020-01-0834PREAI